Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Obesity and cholangiocarcinoma.

Parsi MA.

World J Gastroenterol. 2013 Jan 28;19(4):457-62. doi: 10.3748/wjg.v19.i4.457. Review.

2.

Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.

Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang Y, Wiangnon S, Sripa B, Hong ST.

Asian Pac J Cancer Prev. 2010;11(5):1159-66.

3.

Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.

Jepsen P, Vilstrup H, Tarone RE, Friis S, Sørensen HT.

J Natl Cancer Inst. 2007 Jun 6;99(11):895-7.

PMID:
17551150
4.

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8. Epub 2007 Aug 6.

5.

Risk factors for cholangiocarcinoma.

Ben-Menachem T.

Eur J Gastroenterol Hepatol. 2007 Aug;19(8):615-7. Review.

PMID:
17625428
6.

Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.

Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM.

J Natl Cancer Inst. 2006 Jun 21;98(12):873-5.

PMID:
16788161
7.

Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.

Luke C, Price T, Roder D.

Asian Pac J Cancer Prev. 2010;11(6):1479-85.

8.

Epidemiology of cholangiocarcinoma.

Bergquist A, von Seth E.

Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16. Review.

PMID:
25966423
9.

Intrahepatic cholangiocarcinoma: new insights in pathology.

Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN.

Semin Liver Dis. 2011 Feb;31(1):49-60. doi: 10.1055/s-0031-1272839. Epub 2011 Feb 22. Review.

PMID:
21344350
10.

Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

Palmer WC, Patel T.

J Hepatol. 2012 Jul;57(1):69-76. doi: 10.1016/j.jhep.2012.02.022. Epub 2012 Mar 13. Review. Erratum in: J Hepatol. 2012 Nov;57(5):1160.

11.

[Epidemiology of primary and secondary liver cancers].

Jepsen P, Kissmeyer-Nielsen P.

Ugeskr Laeger. 2008 Apr 14;170(16):1323-5. Danish.

PMID:
18433588
12.

Cholangiocarcinoma: descriptive epidemiology and risk factors.

de Martel C, Plummer M, Franceschi S.

Gastroenterol Clin Biol. 2010 Mar;34(3):173-80. doi: 10.1016/j.gcb.2010.01.008. Epub 2010 Mar 4.

13.

Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.

Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, Olsen JH, McGlynn KA.

Int J Cancer. 2007 Feb 1;120(3):638-41.

14.

Hepatobiliary cancers, version 2.2014.

Benson AB 3rd, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H.

J Natl Compr Canc Netw. 2014 Aug;12(8):1152-82.

PMID:
25099447
15.

Epidemiology of liver cancer: an overview.

Srivatanakul P, Sriplung H, Deerasamee S.

Asian Pac J Cancer Prev. 2004 Apr-Jun;5(2):118-25. Review.

16.

Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea.

Shin HR, Oh JK, Lim MK, Shin A, Kong HJ, Jung KW, Won YJ, Park S, Park SJ, Hong ST.

J Korean Med Sci. 2010 Jul;25(7):1011-6. doi: 10.3346/jkms.2010.25.7.1011. Epub 2010 Jun 17.

17.

Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Malhi H, Gores GJ.

J Hepatol. 2006 Dec;45(6):856-67. Epub 2006 Sep 25. Review.

18.

Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.

Lin CC, Lin PY, Chen YL.

World J Gastroenterol. 2013 Jan 21;19(3):375-80. doi: 10.3748/wjg.v19.i3.375.

19.

The epidemiology of cholangiocarcinoma.

Shaib Y, El-Serag HB.

Semin Liver Dis. 2004 May;24(2):115-25. Review.

PMID:
15192785
20.

Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?

Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, Toledano MB.

J Hepatol. 2012 Apr;56(4):848-54. doi: 10.1016/j.jhep.2011.11.015. Epub 2011 Dec 13.

PMID:
22173164

Supplemental Content

Support Center